Literature DB >> 10618288

Sex-associated differences in the antibody-dependent cellular cytotoxicity antibody response to measles vaccines.

S Atabani1, G Landucci, M W Steward, H Whittle, J G Tilles, D N Forthal.   

Abstract

In some countries, excessive non-measles-related mortality has been observed among female recipients of high-titer measles vaccines. We determined if differences in the immune response to measles vaccines underlie the excessive female mortality by measuring the measles virus (MV)-specific antibody-dependent cellular cytotoxicity (ADCC) antibody response in 65 3-year-old Gambian children immunized with Edmonston-Zagreb medium-titer (EZ) or Schwarz standard vaccines during infancy. Among the 20 females and 22 males with undetectable anti-MV antibodies at the time of immunization, females had significantly lower ADCC than males (median cytotoxicities of 1/100 serum dilutions = 8.4 and 12%, respectively; P = 0.04). This sex-associated difference was present only among the six female and seven male recipients of EZ vaccine (median cytotoxicities = 5.1 and 19.0%, respectively; P = 0.02). There were no significant sex-associated differences in neutralizing antibody activity. Decreased ADCC antibody activity may contribute to the lower survival rate observed in females receiving high-titer measles vaccination.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10618288      PMCID: PMC95833          DOI: 10.1128/CDLI.7.1.111-113.2000

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  14 in total

1.  Expanded programme on immunization (EPI). Safety of high titre measles vaccines.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  1992-11-27

Review 2.  Virus-induced immunosuppression: infections with measles virus and human immunodeficiency virus.

Authors:  M B McChesney; M B Oldstone
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

3.  Pattern of exposure and measles mortality in Senegal.

Authors:  M Garenne; P Aaby
Journal:  J Infect Dis       Date:  1990-06       Impact factor: 5.226

4.  Antibody persistence in Gambian children after high-dose Edmonston-Zagreb measles vaccine.

Authors:  H C Whittle; H Campbell; S Rahman; J R Armstrong
Journal:  Lancet       Date:  1990-10-27       Impact factor: 79.321

5.  Trial of high-dose Edmonston-Zagreb measles vaccine in the Gambia: antibody response and side-effects.

Authors:  H Whittle; P Hanlon; K O'Neill; L Hanlon; V Marsh; E Jupp; P Aaby
Journal:  Lancet       Date:  1988-10-08       Impact factor: 79.321

6.  Immunologic parameters 2 years after high-titer measles immunization in Peruvian children.

Authors:  M E León; B Ward; R Kanashiro; H Hernández; S Berry; A Vaisberg; J Escamilla; M Campos; S Bellomo; V Azabache
Journal:  J Infect Dis       Date:  1993-11       Impact factor: 5.226

7.  Age, sex, and household exposure are associated with the acute measles-specific antibody-dependent cellular cytotoxicity antibody response.

Authors:  D N Forthal; G Landucci; A Habis; M Laxer; M Javato-Laxer; J G Tilles; E N Janoff
Journal:  J Infect Dis       Date:  1995-12       Impact factor: 5.226

8.  Long term impact of high titer Edmonston-Zagreb measles vaccine on T lymphocyte subsets.

Authors:  I M Lisse; P Aaby; K Knudsen; H Whittle; H Andersen
Journal:  Pediatr Infect Dis J       Date:  1994-02       Impact factor: 2.129

9.  Differential mortality by measles vaccine titer and sex.

Authors:  E A Holt; L H Moulton; G K Siberry; N A Halsey
Journal:  J Infect Dis       Date:  1993-11       Impact factor: 5.226

10.  Long-term survival after Edmonston-Zagreb measles vaccination in Guinea-Bissau: increased female mortality rate.

Authors:  P Aaby; K Knudsen; H Whittle; I M Lisse; J Thaarup; A Poulsen; M Sodemann; M Jakobsen; L Brink; U Gansted
Journal:  J Pediatr       Date:  1993-06       Impact factor: 4.406

View more
  6 in total

1.  Race and sex-based differences in cytokine immune responses to smallpox vaccine in healthy individuals.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; Richard B Kennedy; Beth R Larrabee; V Shane Pankratz; Gregory A Poland
Journal:  Hum Immunol       Date:  2013-06-24       Impact factor: 2.850

2.  A large observational study to concurrently assess persistence of measles specific B-cell and T-cell immunity in individuals following two doses of MMR vaccine.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; Megan O'Byrne; V Shane Pankratz; Robert M Jacobson; Gregory A Poland
Journal:  Vaccine       Date:  2011-05-01       Impact factor: 3.641

Review 3.  Sex differences in vaccine-induced humoral immunity.

Authors:  Stephanie Fischinger; Carolyn M Boudreau; Audrey L Butler; Hendrik Streeck; Galit Alter
Journal:  Semin Immunopathol       Date:  2018-12-13       Impact factor: 9.623

4.  Effects of sex and birth weight on non-specific health services use following whole-cell pertussis vaccination: a self-controlled case series analysis.

Authors:  Steven Hawken; Robin Ducharme; Deshayne B Fell; Assaf P Oron; Kumanan Wilson
Journal:  Hum Vaccin Immunother       Date:  2019-04-05       Impact factor: 3.452

5.  Gender differences in measles incidence rates in a multi-year, pooled analysis, based on national data from seven high income countries.

Authors:  Manfred S Green; Naama Schwartz; Victoria Peer
Journal:  BMC Infect Dis       Date:  2022-04-11       Impact factor: 3.090

6.  Profiling of measles-specific humoral immunity in individuals following two doses of MMR vaccine using proteome microarrays.

Authors:  Iana H Haralambieva; Whitney L Simon; Richard B Kennedy; Inna G Ovsyannikova; Nathaniel D Warner; Diane E Grill; Gregory A Poland
Journal:  Viruses       Date:  2015-03-10       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.